A Real-World Study of Second-line Therapies Among Radioiodine-refractory Differentiated Thyroid Cancer (RAI-R DTC) Patients
Clinical trial NCT07770074 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07770074
- Sponsor
- Novartis Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-10-08
- Primary completion
- 2026-10-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.